Compare Amphastar Pharmaceuticals Inc (AMPH) vs Trump Media and Technology Group Corp (DJT) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

DJT trades at $8.54, down 0.12% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported 2025 revenue of $3.68M but a net loss of -$712.06M, with a negative net income margin of -29,098.97%. Recent news highlights a nearly 50% stock decline in 2026 and the cancellation of plans to spin off Truth Social, while the merger with TAE Technologies remains pending.

The outlook is highly speculative with severe financial losses and minimal revenue growth, posing significant risks. Investment potential hinges on the TAE merger and Truth Social's expansion, but high volatility and negative profitability warrant extreme caution for stock investors.